For example, tumor necrosis factor (TNF) blockade may enhance ICI efficacy by supporting tumor-infiltrating lymphocyte survival (100, 101), while IL-6 receptor blockade could induce remission without impairing anti-tumor immunity (100, 102, 103). The gene discussed is TNF; the disease is neoplasm.